Nephrocare Health IPO consists of a ₹353-crore fresh issue and a ₹518-crore offer for sale. Of the fresh issue funds, Nephrocare Health Services intends to use ₹129.1 crore to set up new dialysis centres, ₹136 crore to repay debt, with the balance earmarked for general corporate needs.Read More
US Fed December 2025 Meet: The US Federal Reserve has begun its two-day policy meeting, with the rate decision due Wednesday. After a 25 bps cut in October that brought rates to 3.75%–4.00%, global markets are watching to see if the Fed continues easing, as any move will influence borrowing costs and capital flows worldwide.Read More
Japan’s Topix stock index reached an unprecedented high on Wednesday before paring gains. Investors are closely watching central bank decisions in Japan and the United States. A weaker yen boosted Japanese automakers like Honda and Toyota. The market’s direction hinges on the continuing depreciation of the yen.Read More
Renaissance Investment Managers CIO Pankaj Murarka expects Indian markets to deliver low-teens returns as growth resets and valuations peak. He sees earnings improving in CY26, prefers cash-flow-rich sectors, and remains bullish on IT amid AI-driven demand. Murarka warns of froth in midcaps, defence and EMS, urges caution on IndiGo for now, and remains selective on pricey consumer-tech IPOs.Read More
India’s real estate investment market is evolving with listed REITs and SM REITs, offering retail investors scalable, income-generating exposure to prime commercial assets. With transparency, liquidity, and professional management, these trusts are transforming real estate from high-friction, ownership-driven investing into a regulated, efficient, and accessible investment avenue for individual and institutional investors alike.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
